Correlation Between IShares SP and IShares Nasdaq

Can any of the company-specific risk be diversified away by investing in both IShares SP and IShares Nasdaq at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining IShares SP and IShares Nasdaq into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between iShares SP SmallCap and iShares Nasdaq Biotechnology, you can compare the effects of market volatilities on IShares SP and IShares Nasdaq and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in IShares SP with a short position of IShares Nasdaq. Check out your portfolio center. Please also check ongoing floating volatility patterns of IShares SP and IShares Nasdaq.

Diversification Opportunities for IShares SP and IShares Nasdaq

0.11

Correlation Coefficient

IShares SP  IShares Nasdaq

Average diversification

The 3 months correlation between IShares and IShares is 0.11. Overlapping area represents the amount of risk that can be diversified away by holding iShares SP SmallCap and iShares Nasdaq Biotechnology in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on iShares Nasdaq Biote and IShares SP is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on iShares SP SmallCap are associated (or correlated) with IShares Nasdaq. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of iShares Nasdaq Biote has no effect on the direction of IShares SP i.e., IShares SP and IShares Nasdaq go up and down completely randomly.

Pair Corralation between IShares SP and IShares Nasdaq

Assuming the 90 days trading horizon iShares SP SmallCap is expected to under-perform the IShares Nasdaq. In addition to that, IShares SP is 1.11 times more volatile than iShares Nasdaq Biotechnology. It trades about -0.12 of its total potential returns per unit of risk. iShares Nasdaq Biotechnology is currently generating about 0.05 per unit of volatility. If you would invest  633.00  in iShares Nasdaq Biotechnology on December 24, 2024 and sell it today you would earn a total of  18.00  from holding iShares Nasdaq Biotechnology or generate 2.84% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Together
Strength	Insignificant
Accuracy	98.41%
Values	Daily Returns

iShares SP SmallCap  vs.  iShares Nasdaq Biotechnology

iShares SP SmallCap

Risk-Adjusted Performance

Very Weak

Over the last 90 days iShares SP SmallCap has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of latest uncertain performance, the Etf's basic indicators remain stable and the newest uproar on Wall Street may also be a sign of mid-term gains for the exchange-traded fund private investors.

iShares Nasdaq Biote

Risk-Adjusted Performance

Insignificant

Compared to the overall equity markets, risk-adjusted returns on investments in iShares Nasdaq Biotechnology are ranked lower than 3 (%) of all global equities and portfolios over the last 90 days. In spite of comparatively stable basic indicators, IShares Nasdaq is not utilizing all of its potentials. The newest stock price uproar, may contribute to short-horizon losses for the private investors.

Pair Trading with IShares SP and IShares Nasdaq

The main advantage of trading using opposite IShares SP and IShares Nasdaq positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if IShares SP position performs unexpectedly, IShares Nasdaq can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in IShares Nasdaq will offset losses from the drop in IShares Nasdaq's long position.

The idea behind iShares SP SmallCap and iShares Nasdaq Biotechnology pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Idea Analyzer module to analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas.